NantKwest Prices IPO, Starts Trading Today

Culver City-based NantKwest, the immunotherapy company which is linked to NantWorks and biotech billionaire Dr. Patrick Soon-Shiong, has priced its IPO, saying it will sell 8,288,000 shares of its common stock at $25.00 per share. NantKwest--which until recently was known as Conkwest--will begin trading this morning on the Nasdaq Global Select Market as NK. NantKwest's IPO price is above the company's initial estimated IPO range of $20.00 to $23.00 per share. Dr. Soon-Shiong owned 62.1 percent of NantKwest before the IPO.